JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1989; 13:1622-1628
© 1989 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, M.
Right arrow Articles by DeMaria, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Smith, M.
Right arrow Articles by DeMaria, A.

Left heart opacification with peripheral venous injection of a new saccharide echo contrast agent in dogs

MD Smith, JL Elion, RR McClure, OL Kwan, and AN DeMaria

Division of Cardiovascular Medicine, University of Kentucky College of Medicine, Lexington 40536-0084.

Opacification of the left heart chambers after venous injection of echo contrast agents with transpulmonary capabilities has been difficult to achieve because of a lack of availability of a biodegradable nontoxic agent that produces uniformly small microbubbles. SHU-508 is a new saccharide echo contrast agent that produces bubble sizes from 2 to 8 microns in diameter, capable of traversing the pulmonary capillary bed and resulting in left heart contrast. The echo intensity produced by this agent was compared with that of agitated saline solution, indocyanine green and SHU-454 (another experimental saccharide agent for right-sided contrast) during 136 injections in eight dogs. Videotaped two-dimensional echographic images were digitized and analyzed with the use of videodensitometry for peak right and left ventricular intensity, pulmonary transit times and time of persistence of contrast. The highest right ventricular intensity value (3,594 +/- 1,393) was achieved with SHU-508 (p less than 0.05 compared with the other agents). The right ventricular contrast seen with SHU-508 also persisted for a longer period (22.8 +/- 12 s) than with the standard agents (p less than 0.001). Left ventricular contrast with SHU-508 was visually evident in all 42 injections, whereas the peak left ventricular intensity was 35% as bright as that produced in the right ventricle by the same agent. Peak left ventricular intensity values from SHU-508 were compared with those from agitated saline solution injected from the pulmonary capillary wedge position in four dogs. SHU-508 produced brighter left ventricular intensity (1,281 +/- 607) compared with that obtained with the saline-wedge technique (p les than 0.002).(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
S. Aronson
Myocardial Contrast Echocardiography: Is it Ready to be Used as a Clinical Tool in the Operating Room?
Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 1997; 1(1): 4 - 15.
[PDF]


Home page
Journal of Diagnostic Medical SonographyHome page
A. D. Waggoner, V. G. Davila-Roman, B. Barzilai, and J. E. Perez
Contrast Two-Dimensional Echocardiography Provides Clinical Information Not Available with Color Flow Imaging
Journal of Diagnostic Medical Sonography, January 1, 1992; 8(1): 2 - 13.
[Abstract] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1989 by the American College of Cardiology Foundation.